Physician profile
Christopher Clark
NPI 1215257217
$5,841.35
in general payments reported to CMS, 2019-2025
23 companies · $650 in 2025
The $650 reported for 2025 was more than what 82% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,538 · 2020: $241 · 2021: $184 · 2022: $338 · 2023: $1,006 · 2024: $1,885 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,147 · Travel and Lodging: $1,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,147.06 |
| Travel and Lodging | $1,392.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,620.11 | 2024-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Medtronic USA, INC. | $1,271.95 | 2019-2020 | |
| Boston Scientific Corporation | $712.62 | 2019-2025 | Wavewriter Alpha Prime 16, Patient Trial Kit |
| Pacira Pharmaceuticals Incorporated | $685.57 | 2023-2025 | Iovera, Zilretta |
| Horizon Therapeutics Plc | $260.60 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $206.52 | 2019-2025 | Xtampza, Belbuca |
| Depuy Synthes Sales INC. | $152.54 | 2019-2025 | Peak, Orthovisc, Monovisc |
| Electronic Waveform Lab, INC. | $142.46 | 2021-2025 | |
| Abbott Laboratories | $128.04 | 2020-2022 | |
| Ani Pharmaceuticals, INC. | $109.53 | 2025 | Purified Cortrophin Gel |
| Fidia Pharma USA INC. | $104.68 | 2019-2024 | Triluron, Hymovis, Hyalgan |
| Abbvie INC. | $94.15 | 2022-2024 | Ubrelvy |
| Avanos Medical | $73.25 | 2021-2024 | Generator |
| Ferring Pharmaceuticals INC. | $58.12 | 2019-2020 | |
| Radius Health, INC. | $43.30 | 2023-2024 | Tymlos |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $32.63 | 2019-2020 | |
| Pacira Therapeutics, INC. | $29.24 | 2020-2021 | |
| Painteq LLC | $27.84 | 2024 | Painteq |
| Grt US Holding, INC. | $27.42 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.20 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.74 | 2022 | |
| Vertos Medical, INC. | $14.20 | 2022 | |
| Zyla Life Sciences, INC. | $11.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.